Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial

Table 1

Genotyping frequencies of HCV-positive patients in the control and treatment groups.

Groups	HCV genotype	Frequency (%)
Control	3a	14 (94.23)
Treatment	3a	13 (86.66)
Control	2b	1 (0.066)
Treatment	2b	2 (1.33)